Molecular prenatal diagnosis in 2 pregnancies at risk for spondyloepiphyseal dysplasia congenita

Clinica Chimica Acta

Volumn 387, Issue 1-2, 2008, Pages 153-157

  Xia, Xin Yi ^a   Cui, Ying Xia ^a   Huang, Yu Feng ^a   Pan, Lian Jun ^a   Feng, Yao ^a   Yang, Bin ^a   Li, Xiao Jun ^a   Zhu, Pei Yuan ^a   Shi, Yi Chao ^a   Liang, Quan ^a  

^a JINLING HOSPITAL   (China)

Author keywords

COL2A1 gene; Molecular prenatal diagnosis; Spondyloepiphyseal dysplasia congenita

Indexed keywords

COLLAGEN TYPE 2;

ADULT; AMNION FLUID CYTOLOGY; ARTICLE; CASE REPORT; COL2A1 GENE; FEMALE; FETUS; FETUS ECHOGRAPHY; GENE; GENE MUTATION; HIGH RISK PREGNANCY; HUMAN; MALE; PRIORITY JOURNAL; SHORT TANDEM REPEAT; SPONDYLOEPIPHYSEAL DYSPLASIA;

BASE SEQUENCE; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DNA PRIMERS; FEMALE; HUMANS; KARYOTYPING; OSTEOCHONDRODYSPLASIAS; PREGNANCY; PRENATAL DIAGNOSIS;

EID: 35748949590     PISSN: 00098981     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cca.2007.09.006     Document Type: Article

References (20)

1. Anderson I.J., Goldberg R.B., Marion R.W., Upholt W.B., and Tsipouras P. Spondyloepiphyseal dysplasia congenita: genetic linkage to type II collagen (COL2AI). Am J Hum Genet 46 (1990) 896-901
2. Chitty L.S., Tan A.W., Nesbit D.L., Hall C.M., and Rodeck C.H. Sonographic diagnosis of SEDC and double heterozygote of SEDC and achondroplasia-a report of six pregnancies. Prenat Diagn 26 (2006) 861-865
3. Tiller G.E., Weis M.A., Polumbo P.A., et al. An RNA-splicing mutation (G + 5IVS20) in the type II collagen gene (COL2A1) in a family with spondyloepiphyseal dysplasia congenital. Am J Hum Genet 56 (1995) 388-395
4. James P.A., Shaw J., du Sart D., Craig E., Bateman J.F., and Savarirayan R. Molecular diagnosis in a pregnancy at risk for both spondyloepiphyseal dysplasia congenita and achondroplasia. Prenat Diagn 23 (2003) 861-863
5. Xia X., Cui Y., Huang Y., et al. A first familial G504S mutation of COL2A1 gene results in distinctive spondyloepiphyseal dysplasia congenita. Clin Chim Acta 382 (2007) 148-150
6. Jarrett K.L., Michaelis R.C., Phelan M.C., Vincent V.A., and Best R.G. Microsatellite analysis reveals a high incidence of maternal cell contamination in 46, XX products of conception consisting of villi or a combination of villi and membranous material. Am J Obstet Gynecol 185 (2001) 198-203
7. Brautigam S., Kujat A., Kirst P., Seidel J., Luleyap H.U., and Froster U.G. DHPLC mutation analysis of phenylketonuria. Mol Genet Metab 78 (2003) 205-210
8. Kirk J.S., and Comstock C.H. Antenatal sonographic appearance of spondyloepiphyseal dysplasia congenital. J Ultrasound Med 9 (1990) 173-175
9. Donnenfeld A.E., and Mennuti M.T. Second trimester diagnosis of fetal skeletal dysplasias. Obstet Gynecol Surv 42 (1987) 199-217
10. Reginato A.J., Passano G.M., Neumann G., et al. Familial spondyloepiphyseal dysplasia tarda, brachydactyly, and precocious osteoarthritis associated with an arginine 75-cysteine mutation in the procollagen type II gene in a kindred of Chiloe Islanders. I. Clinical, radiographic, and pathologic findings. Arthritis Rheum 37 (1994) 1078-1086.
11. Nishimura G., Haga N., Kitoh H., et al. The phenotypic spectrum of COL2A1 mutations. Hum Mutat. 26 (2005) 36-43
12. Mortier G.R., Weis M., Nuytinck L., et al. Report of five novel and one recurrent COL2A1 mutations with analysis of genotype-phenotype correlation in patients with a lethal type II collagen disorder. J Med Genet 37 (2000) 263-271
13. Murray L.W., Bautista J., James P.L., and Rimoin D.L. Type II collagen defects in the chondrodysplasias. I. Spondyloepiphyseal dysplasias. Am J Hum Genet 45 (1989) 5-15
14. Kujat A., Veith V.P., Faber R., and Froster U.G. Prenatal diagnosis and genetic counseling in a case of spina bifida in a family with Waardenburg syndrome type I. Fetal Diagn Ther 22 (2007) 155-158
15. Gupta N., Bianchi P., Fermo E., et al. Prenatal diagnosis for a novel homozygous mutation in PKLR gene in an Indian family. Prenat Diagn 27 (2007) 17-18
16. Barragan E., Bolufer P., Perez M.L., Prieto F., and Sanz M.A. Molecular detection of Spanish deltabeta-thalassemia associated with beta-thalassemia identified during prenatal diagnosis. Clin Chim Acta 368 (2006) 195-198
17. McAdoo S.L., Bleigh O.C., Simmons Jr. G.M., and Wenger S.L. Maternal cell contamination in an amniotic fluid sample. Prenat Diagn 22 (2002) 737
18. Lapaire O., Lu X.Y., Johnson K.L., et al. Array-CGH analysis of cell-free fetal DNA in 10 mL of amniotic fluid supernatant. Prenat Diagn 27 (2007) 616-621
19. Lapaire O., Bianchi D.W., Peter I., et al. Cell-free fetal DNA in amniotic fluid: unique fragmentation signatures in euploid and aneuploid fetuses. Clin Chem 53 (2007) 405-411
20. Lapaire O., Stroh H., Peter I., et al. Larger columns and change of lysis buffer increase the yield of cell-free DNA extracted from amniotic fluid. Clin Chem 52 (2006) 156-7